Capital International Investors Astrazeneca PLC Transaction History
Capital International Investors
- $488 Billion
- Q1 2025
A detailed history of Capital International Investors transactions in Astrazeneca PLC stock. As of the latest transaction made, Capital International Investors holds 31,285,560 shares of AZN stock, worth $2.19 Billion. This represents 0.47% of its overall portfolio holdings.
Number of Shares
31,285,560
Previous 37,507,159
16.59%
Holding current value
$2.19 Billion
Previous $2.46 Billion
6.43%
% of portfolio
0.47%
Previous 0.48%
Shares
31 transactions
Others Institutions Holding AZN
# of Institutions
1,428Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$3.99 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.84 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.49 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.22 Billion0.19% of portfolio
-
Franklin Resources Inc San Mateo, CA21.1MShares$1.47 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $216B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...